Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orthostatic Effects of Apomorphine in Late Stage PD
NCT00145171Phase 3Completed
- Sponsor
- Viatris
- Start
- Feb 2001
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing Apomorphine with Placebo (2 arms). Primary endpoints: Adverse event assessments and Change in Unified Parkinson's Disease Rating Scale (UPDRS) Motor Score. Started Feb 2001; status: completed.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00145171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145171.